Global Licensing agreement

Article

UK firm UltraVision CLPL has agreed on a global licensing agreement with Bausch + Lomb for the marketing and sales of KeraSoft contact lens.

UK firm UltraVision CLPL has agreed on a global licensing agreement with Bausch + Lomb for the marketing and sales of KeraSoft contact lens.

The move will enable UltraVision to distribute the lens globally and reach a wider market. Jerry Warner, Vice President of marketing and general manager at Bausch + Lomb, Global Contact Lens, said: "Extending the KeraSoft technology allows the lab to expand the ability of practitioners to offer life-changing vision correction to a wider range of patients who have a variety of irregular cornea conditions resulting from keratoconus and pellucid marginal degeneration."

The custom-made soft lens has been manufactured from silicone hydrogel materials and has been developed to correct irregular corneas, pellucid marginal degeneration and keratoconus.

Joseph Barr, vice president of Global Clinical and Medical Affairs and Professional Services, Vision Care, Bausch + Lomb, said: “This technology has totally transformed my view of contact lens management of keratoconus and irregular cornea patients. The visual results and enhancement of life are true advances.”

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.